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Abstract: Studies into the interactions between glia/immune cells and neurons have focused on the induction of patho-
logical (neuropathic or inflammatory) pain. Growing evidence of close relationships between peripheral and central glia 
and pathological pain has emerged during the last 2 decades. Numerous experimental studies have showed the release of 
cytokines and inflammatory neuropeptides from peripheral and central terminals of primary sensory neurons and from ac-
tivated peripheral and central glia after nerve injury (crush, ligation or transection), which in turn act in a paracrine or 
autocrine manner. Cytokines induce the synthesis of algogens (pain-inducing substances such as prostaglandin) which 
leads to the primary (peripheral) or secondary (central) sensitization responsible for hyperalgesia or allodynia under in-
flammatory conditions. The review has also highlighted the role of thermo transient receptor potential (TRP) channels 
TRPV1, TRPA1 and TRPM8 in the induction of pathological pain. The noxious heat sensor TRPV1 has an overt role in 
noxious heat hyperalgesia or allodynia, whereas TRPA1 and TRPM8 seem to have roles in noxious cold or mechanical al-
lodynia, although results are inconsistent. Close mutual interrelationships between immune and glial cells and thermoTRP 
channels via cytokines or pro-inflammatory neuropeptides cannot be ignored when attempting to explain the induction 
and continuation of pathological pain. Investigations on the initial signals sent to the central area (superficial dorsal horn) 
remote from injured (or infectious) sites are a key point to clarify the mechanisms of pathological pain. 
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1. INTRODUCTION 
 In this report, inflammation is used as a synonym of neu-
ropathy; the former indicates the phenomena as a result of 
many kinds of the latter. Accordingly, pathological pain 
means both inflammatory and neuropathic pains. 
 Dubner and Gold [1] summarized the mechanisms of 
pain in the introduction to their paper “The Neurobiology of 
Pain” (National Academy of Sciences colloquium). They 
pointed to the complex mechanisms of pain, including 1) 
specialized receptors, 2) stimulus transduction mechanisms, 
3) ion channel modulation, 4) rapid and slow activity involv-
ing excitatory and inhibitory transmitters and their receptors, 
5) amplification (neuronal plasticity) of related signals de-
pending on activity and signals at sites in the peripheral 
nervous system (PNS) and central nervous system (CNS), 
and 6) the distribution of environmental signals and their 
interactions with learned memories at higher centers (brain 
cortices). On the other hand, four-state-dependent sensory 
(pain) processing occurs in the somatosensory system [2]. 
The first state is responsible for the normal processing of 
low-(innocuous) and high-intensity peripheral stimuli (acute 
pain with tissue damage; a transient response to threshold-
exceeding stimuli). The second is the activation of nocicep-
tive C-fibers with sufficient intensity or duration to induce  
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rapid posttranslational changes in membrane-bound recep-
tors of dorsal horn neurons, modifying their excitability 
(central sensitization). The third is activity-dependent 
changes in the expression of functional genes in dorsal root 
ganglions (DRGs) and dorsal horn neurons occurring several 
hours after noxious stimulation. The potentiation by gene 
transcription leads to an enhanced responsiveness to noxious 
stimuli for longer duration. The fourth sensory paradigm is 
induction by peripheral inflammation. In this fourth state, 
either low-intensity Aβ or C-fiber inputs are considered to 
initiate central sensitization by sprouting. A combination of 
activity-dependent and signal molecule-mediated transcrip-
tional and posttranslational changes occur in the primary 
sensory and secondary dorsal horn neurons (concomitant 
features of peripheral and central sensitization).  
 The foregoing assumptions are very important for the 
study of pain mechanisms even the present time, however, 
interactions between glial or immune cells and nociceptive 
neurons were not clearly described until now. Based on the 
previous reports, we attempted to reveal this point in the 
pathological (abnormal) pain, because there is mounting evi-
dence of interactions between sensory neurons and periph-
eral or central glial cells via the reciprocal influences of cy-
tokines, neuropeptides, and eicosanoids during pathophysi-
ological conditions. 
 Pathological pain (hyperalgesia: acute or persistent pain 
induced by peripheral or central nerve injury, allodynia: pain 
induced by innocuous physical stimuli under normal condi-
tions) can be caused by infections, damage, envenomation, 
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and injury (including experimental axotomy) to the periph-
eral nerves or spinal cord. Sensitization can be categorized as 
peripheral or central. Peripheral sensitization involves a) the 
activation of peripheral nerve nociceptors (capsaicin recep-
tors: TRPV1) and glial cells within DRGs, and b) a pheno-
typic switch in primary sensory neurons after the intraplantar 
injection of algogens (i.e., larger type DRG cells change to 
express substance P (SP) [3] or the capsaicin-receptor, vanil-
loid receptor 1 (VR1) [4]). Central sensitization involves the 
activation of microglia and astroscytes mainly in the spinal 
superficial dorsal horn underlying the interaction of immune 
cells and intrinsic neurons via cytokines, chemokines and 
neuropeptides. It also includes the activation of brain stem 
inhibitory neurons which descend to the spinal dorsal horn 
from the rostral ventromedial medulla (RVM), and indirectly 
stimulate secondary nociceptive neurons via the inactivation 
of inhibitory interneurons [5]. Accordingly, since this de-
scending pathway tonically facilitates the spinal nociceptors, 
spinal cord transection and inactivation of the neurons in the 
RVM can reduce central sensitization (pain relief) [5].  
 Moreover, central sensitization may occur through the 
sprouting (structural organization) of large Aβ myelinated 
fibers into lamina II (the central terminating area of nocicep-
tive C-fibers) in the spinal dorsal horn after nerve damage 
[6-8] or the topical application of capsaicin [9]. Thus, pro-
gressive tactile hypersensitivity in inflamed animals was 
thought to be due to sprouting of low threshold Aβ fibers 
which normally do not sense nociception [10]. Nerve growth 
factor (NGF) immunoreactive activation of microglia, a sub-
set of astrocytes and putative Schwann cells in dorsal entry 
zones, was demonstrated in the injured area 1 to 2 weeks 
after spinal cord transection [11]. NGF released from these 
cells was assumed to promote the sprouting of primary affer-
ents in the spinal dorsal horn after injury [11]. 
 Several reviews specifically infer how central and pe-
ripheral glia (including mast cells [12-14]) is involved in the 
induction or propagation of neuropathic pain. Watkins and 
Maier [14] repeatedly stated the importance of interactions 
between immune cells (T-lymphocytes, macrophages, neu-
trophils, dendritic cells) including central glia (microglia), 
peripheral glia (satellite cells, Schwann cells), endothelium, 
fibroblasts and mast cells (immune and inflammatory cells), 
and central and peripheral neurons. Glia and immune cells 
release inflammatory cytokines (tumor necrosis factor, and 
interleukin-1, 6) in response to pathological conditions [14]. 
Thus, neuro-immune interactions were stressed to participate 
in the development of peripheral neuropathies [15, 16]. Im-
mune suppressants such as cyclosporine A are thought to 
reduce neuropathic pain [15]. Complex regional pain syn-
drome (CRPS) I (reflex sympathetic dystrophy) and CRPS II 
(causalgia), mirror-image (uninjured side) pain and extrater-
ritorial pain changes, and clinical back pain are explained by 
immune or autoimmune effects on the peripheral and central 
nervous system [14].  
 For the first time, a chronological description of the cy-
tokines released from immune and glial cells under patho-
physiological conditions is available for understanding the 
above interrelationships. Subsequently, capsaicin’s noxious 
heat sensor TRPV1, and cool and cold TRP channels TRPA1 
and TRPM8, respectively, should be taken into consideration 
for the induction of inflammatory pain and anti inflammatory 
pain. 
2. CYTOKINES, EICOSANOIDS AND THEIR CELL 
SOURCE 
2.1. Cytokines and Eicosanoids 
 Cytokines are chemical mediators produced in associa-
tion with cell growth and differentiation as well as activation 
of the immune system and inflammatory responses [17, 18]. 
Cytokines, their abbreviations and cell source are listed in 
Tables 1 and 2. 
 Several types of lipids known as signaling molecules act 
by binding to cell surface receptors. The most important of 
these molecules are prostaglandins (PG), prostacyclin, 
thromboxianes and leukotriens, known collectively as eico-
sanoids. They stimulate blood platelet aggregation, inflam-
mation, and smooth-muscle contraction in target tissues. Due 
to their rapid degradation, they are believed to act locally via 
autocrine or paracrine signals. Eicosanoids are synthesized 
from arachidonic acid (AA) derived from membrane phos-
pholipids. The first step in the synthesis of PG is the conver-
sion of AA to prostaglandin H2 (PGH2) by cyclooxygenase 
(COX). Aspirin and other nonsteroidal anti-inflammatory 
drugs target this enzyme, thereby reducing inflammation and 
pain by inhibiting the synthesis of PG. Besides, PG stimu-
lates cell proliferation and the development of cancer.  
 Increased PG synthesis is a specific response to acute and 
chronic inflammation. It is enhanced by a number of proin-
flammatory cytokines such as IL-1, TGF-β and PDGF which 
are produced at injured sites. Production of IL-1 and IL-6 is 
Table 1. Cytokines and Abbreviations 
Cytokines Abbreviations 
interleukins IL(interleukin)-1α, IL-1β, IL-2～IL-15 
chemokines IL-8/NAP (neutrophil activating protein)-1, NAP-2, MIP (macrophgeinflammatory protein, MCAF (monocyte chemotactic 
and activating factor)/MCP (monocyte chemotactic protein)-1, MGSA (melanoma growth stimulatory activity), RANTES 
(regulated upon activation normal expressed and secreted), TNF (tumor necrosis factor)-α, β, IFN (interferon)-α, β, γ, G 
(granulocyte)- or M (macrophage)-CSF (colony stimulating factor) 
growth factors EGF (epidermal growth factor), FGF (fibroblast growth factor), PDGF (platelet-derived growth factor), TGF (transforning 
growth factor)-α, β, ECGF(endothelial cell growth factor), NT (neurotrophin)-3～6, GDNF (glial cell linederived neurotro-
phic factor), LIF (leukemia inhibitory factor = neuropoietins),CNTF (ciliary neurotrophic factor), OM (oncostatin M), IL-6 
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Table 2. Cell Soruce of Cytokines Under Patholpgical Conditions 
Cell  Cytokines  Conditions 
neurons IL-1β, IL-6, FGF, TGF-β peripheral infections, endotoxins, ischemia 
microglia IL-2, NGF, FGF, PDGF, LT, NO, PLE IL-1β, IL-6, IL-8, PNS and CNS infections, brain injury, meningitis,multiple sclerosis, 
Alzheimer disease, peripheralnerve ligation 
astroglia IFN-γ, MIP-1, MIP-2, TNF-α, β, TGF-β, PG  
lymphocytes IL-1β, IL-2, IL-6, TNF-α, β, IFN-γ  multiple screlosis 
macrophages IL-1β, IL-2, IL-6  Alzheimer disease 
endothelial cells IL-1β, IL-6, FGF, TGF-β ischemia 
mast cells NGF, TNF-α, NK-1, TT, IL-1, IL-6, HIS inflammation, injury 
HIS : Histamine, LT : Leukotriens, NO : Nitric oxide, PG : Prostaglandin, PLE : Proteolytic enzyme, TT : Tryptase 
suggested to be induced by the nonapeptide bradykinin (BK) 
and TNF-α in a hyperalgesic response. These cytokines pri-
marily promote the production of prostaglandin, causing an 
increase in the transcription of enzymes, such as COX and 
phospholipase A2 (PLA2) [19]. One of the effects of pros-
taglandins E2 and I2 (PGE2, PGI2: prostanoids) is to sensitize 
afferent fibers (peripheral sensitization) inducing pain.  
 Despite difficulty in confirming the passage of cytokines 
into the brain, increases in cytokine protein content and 
mRNA expression suggest that many cytokines are ex-
pressed within the brain and isolated cells of the CNS [17]. 
Immune cells are key candidates of the source of cytokines, 
because they are able to invade the brain after injury or in-
flammation [17]. However, since these myelomonocytic 
cells reach the brain a few hours after injury, early cytokines 
may be produced by cells within the brain [17]. The primary 
source of cytokines seems to be microglia, but the possibility 
of neurons, astroglia, and endothelial cells can not be ex-
cluded [17]. 
2.2. Cytokine Receptors and the Role of Cytokines 
 Receptors for IL-1, 2, 3, and 6, TNF-α, and many growth 
factors are present in the brain especially the hypothalamus 
and hippocampus. Ligands such as IL-3 to IL-7, IL-9, G-
CSF, LIF and CNTF can bind to hematopoietic cytokine-
receptors. Another member of this family is a 130kD glyco-
protein (gp130) that couples with the binding proteins of IL-
6, IL-11, LIF, OM and CNTF. In the case of CNTF, LIF and 
OM receptors, the active receptor complex is formed by LIF-
receptor β chain (LIF-Rβ) together with gp130 [17]. Both 
gp130 and LIF-Rβ act as signal transducers. They activate 
tyrosine kinases (Trk) within the cell, due to receptor-
complex formation triggered by the binding of cytokines.  
 The high-affinity neurotrophin receptors are for a family 
of Trk. Each Trk exhibits specific affinity, i.e., TrkA for 
NGF, TrkB for BDNF, and TrkC for NT-3. These receptors 
are widely distributed throughout the PNS and CNS. The 
low-affinity NGF receptor p75 is a member of a family that 
includes the TNF-receptors (type I and type II), CD30, CD40 
(gene products responsible for apoptosis) [18] and the Fas (a 
member of the TNF receptor family, apoptotic factor) anti-
gen receptor. Schwann cells and astrocytes also have numer-
ous receptors for neuropeptides and cytokines. The many 
receptors on satellite glial cells (SGC) in DRGs or trigeminal 
ganglions (TGs) have been reviewed [20].  
 It is difficult to assess the effects of proinflammatory 
cytokines (IL-1β and TNF-α) in normal brain tissue because 
of very low concentrations, regional differences, and a rapid 
turnover [20]. However, a role as modulators in sleep and 
feeding as well as proinflammatory mediators in normal 
brain function was stressed for IL-1β and TNF-α [21]. One 
of the physiological roles of cytokines is to maintain homeo-
stasis, but excessive production can damage the body. Ex-
perimental evidence that cytokines can modulate systemic 
function by acting directly on the brain has been obtained by 
the injection of cytokines and their antibodies into the brain. 
These studies showed the aggravation and alleviation of 
pathological symptoms by cytokines and antibodies, respec-
tively. Many cytokines and their receptors are distributed 
widely in the PNS and CNS [17]. Expression and activity 
levels of cytokines are increased under conditions of ‘stress’, 
such as chronic inflammatory disease, tumor growth, infec-
tion and trauma [17]. If extreme tissue trauma or systemic 
insults occur, cytokines excessively released from the injured 
tissue can enter the circulatory system [17]. As a result, acute 
and chronic production of cytokines at injured sites is con-
sidered a cause of pathological conditions.  
 Each member of the cytokine family can influence the 
peripheral and central nervous system, similar to the regula-
tion of inflammatory and immune cells [17]. Peripherally 
produced IL-1 and TNF-α influence the brain indirectly, be-
cause they incite the production of IL-6 in various tissues 
[17]. Since centrally administered IL-1 increases the periph-
eral synthesis of IL-6, the central and peripheral production 
of cytokines may be regulated mutually [17].  
2.3. Effects of Cytokines in Experimental Conditions 
 Subthreshold doses of TNF applied to injured or unin-
jured DRGs ipsilateral to ligated spinal nerve induced tactile 
allodynia, indicating a broader spinal sensitization (central 
sensitization) [22]. It is speculated that the applied NGF or 
up-regulated NGF production in areas inflamed due to injury 
directly affects peripheral nociceptors (TRPV1) and mast 
cells leading to the release of NGF, resulting in hyperalgesia 
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to heat (peripheral sensitization) [23]. Up-regulation of N-
Methyl-D-Asparate (NMDA) receptors by PKC, rous sar-
coma virus’s oncogene (Src), and an inflow of sodium ion 
was implicated in the central sensitization (post synaptic 
dorsal horn neuron), i.e., hyperalgesia or allodynia [24]. 
 BDNF is a neurotransmitter or neuromodulator in small 
diameter nociceptive neurons. BDNF is synthesized in these 
neurons and packaged in dense core vesicles [25]. The 
BDNF-expressing nociceptive primary afferents terminate in 
the superficial dorsal horn (lamina I-II). The post synaptic 
neurons in the superficial dorsal horn express the TrkB re-
ceptor (a high-affinity receptor for BDNF). The intrinsic 
spinal neurons began to express c-fos and exhibited an in-
crease in electrophysiological excitability on the application 
of BDNF in spinal cord preparations, but a reduction in no-
ciceptive behavioral responses on the intrathecal (i.t.) ad-
ministration of TrkB-IgG before the subcutaneous (s.c.) in-
jection of formalin into hind paws [25]. Increased release of 
BDNF from central terminals of nociceptive afferents and 
TrkB expression in spinal neurons may occur in the dorsal 
horn under pathophysiological conditions (inflammation 
induced by injury). The potentiation of BDNF and TrkB en-
hances phosphorylation of the NMDA receptor, leading to 
the induction and maintenance of central sensitization [25]. 
 The inflammatory peptide BK can sensitize nociceptors 
when stimulated by heat. BK activates both phospholipase C 
(PLC) and PLA2, thereby releasing potential intracellular 
signaling molecules (diacyl glycerol, inositol 1,4,5-
triphosphate: IP3) through hydrolysis of the inner plasma 
membrane phospholipid phosphatidylinositol 4,5-
bisphosphate [PIP2 or PtdIns(4,5)P2], which in turn activate 
PKC and Ca2+-mobilization leading to the phosphorylation 
of heat receptors (for instance, the capsaicin receptor, 
TRPV1) [26]. Dephosphorylation by a calcium-dependent 
phosphatase, calcineurin, desensitizes the heat-activated or 
capsaicin-gated channel. Thus, the activity of the channel is 
regulated by phosphorylation and dephosphorylation [26]. 
PKCγ (γ isoform of PKC)-null mice showed no defect in 
terms of acute pain, comparable to wild-type mice [27]. In 
contrast, PKCγ-null mice showed a significant decrease of 
exaggerated responses (mechanical and thermal allodynia) to 
thermal and mechanical stimuli after partial sciatic nerve 
ligation [27]. It was concluded that partial nerve injury could 
not induce hyperexcitability of PKCγ interneurons in the 
inner lamina II in PKCγ null mice [27]. That is, PKCγ is 
likely to play a major role in persistent neuropathic pain. The 
role of proinflammatory cytokines (particularly, IL-1β, IL-6, 
and TNF-α) in inflammatory pain was recently reviewed 
[28]. 
2.4. Interactions of Neuropeptides and Cytokines be-
tween Neurons and Glia 
 Activated and reactive microglia in the CNS after partial 
peripheral nerve ligation are known to produce cytokines, 
such as PG, leukotriens, nitric oxide (NO), proteolytic en-
zymes and excitatory amino acids (glutamate or asparate). 
Substance P (SP, 10-10-10-8 M) elicited the dose-dependent 
production of PGE as well as thromboxane B2 (TXB2), de-
rivatives of AA, via the actions of COX in cultured brain  
 
astrocytes from the rat [29]. Addition of the COX inhibitor 
indomethacin to astrocyte cultures after exposure to SP, re-
duced the production and release of PGE. The stimulatory 
effect of SP on PGE production was abolished by immu-
noadsorption of SP. Accordingly, the stimulatory effect of 
SP is clear in astrocytes. 
 Acting on metabotrophic receptors, glutamate stimulated 
the release of AA from brain (striatal) astrocytes extracted 
from the mouse embryo. In turn, AA seems to inhibit the 
uptake of glutamate into astrocytes, leading to potentiation 
of the NMDA-evoked current (excitation) in neurons [30]. 
That is, neurons and neighboring astrocytes are hot spots of 
the actions of AA [30].  
 An evidence has showed interaction between the Ca2+-
dependent (elevation of Ca2+ levels) release of glutamate 
from astrocytes and signaling to neighboring neurons, 
thereby modulating neuronal activity [31]. In addition, it was 
demonstrated that astroglia can modulate synaptic transmis-
sion, in a high-resolution study of rat hippocampal neurons 
in culture [31]. Perisynaptic Schwann cells also modulate 
transmitter release at the frog neuromuscular junction. The 
neurotransmitters released from the synapses can spill over 
from the synaptic cleft and arrive at neurotransmitter recep-
tors in adjacent astrocytes or perisynaptic Schwann cells, 
followed by an increase in the intracellular Ca2+ concentra-
tion in glial cells. The increase in Ca2+ levels incites the re-
lease of glutamate from glial cells, which feeds back to the 
presynaptic nerve terminals for the modulation of synaptic 
neurotransmission (decrease of glutamate: inhibition), i.e., 
via tripartite synapses [31].  
 Galanin, neuropeptide Y and calcitonin gene-related pep-
tide (CGRP)-immunoreactivity were increased in nerve fi-
bers, interneurons and glial cells in the gracil nucleus after 
chronic constriction injury (CCI) of the rat sciatic nerve [32]. 
Galanin, neuropeptide Y, and CGRP mRNA was not de-
tected on the ipsilateral side of the gracil nucleus by in situ 
hybridization [32]. The increase in neuropeptides in the 
gracil nucleus was assumed to be derived from lumbar DRG 
cells after CCI, thereby allowing neuropeptides to be taken 
up by gracil neurons and glial cells [32]. 
3. THE PARTICIPATION OF GLIA IN PATHOLOGI-
CAL PAIN 
 Relevant papers from the last decade are examined in this 
section. The participation of spinal cord microglia and astro-
cytes in hyperalgesia is a new and dramatic finding, because 
glia without axons in the CNS had not been believed to have 
any role in neuronal function [33]. Spinal dorsal horn glias 
are now known to be activated in response to s.c. inflamma-
tion, s.c. yeast cell walls, i.p. bacteria, peripheral nerve and 
spinal cord trauma (neuropathic conditions after nerve con-
striction or transection), bone cancer, and immune activation 
in the spinal cord, all of which incite hyperalgesia [33]. 
Namely, glial activation affects pathological pain rather than 
normal acute pain [33]. Activated glia (also mast cells [12]) 
release IL-1, IL-6 and TNF and these receptors are expressed 
in both neurons and glia [12, 33]. These proinflammatory 
cytokines are thought to reinforce pain in the spinal cord 
[33].  
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3.1. Glial Activation in Experimental Neuropathy 
 Watkins et al., [34] studied the effects of several glial 
metabolic inhibitors [fluorocitrate (inhibitor of astrocyte ac-
tivation), CNI-1493 (tetravalent guanylhydrazone com-
pound, inhibitor of nitric oxide synthesis and cytokine), 
TNF-bp (binding protein, antagonist of TNF-α)] in hyperal-
gesic conditions (shortening of tail flick latency) after forma-
lin (an algesic chemical) injections using the rat spinal cord. 
They found that fluorcitrate and CNI-1493 but not TNF-bp 
inhibited formalin-induced hyperalgesia, suggesting the par-
ticipation of glia in the mediation of hyperalgesia. The role 
of IL-1, TNF-α, and NO produced by glia was emphasized 
[34]. Mechanical allodynia was induced by partial ligation of 
the sciatic nerve (PSNL) in rats [35]. Allodynic behavior was 
closely associated with an enhancement of the immunoreac-
tivity of complement receptor C3bi (OX42, marker for mi-
croglia), major histocompatibility complex II (OX6, marker 
for microglia) and glial fibrillary acidic protein (GFAP, 
marker for astroglial activation) in the superficial dorsal horn 
[35]. These results strongly suggested a role for glia in neu-
ropathic pain. 
 Hyperalgesia is an acute phase response to a bacterial or 
viral infection, protecting the inner body through fever [36]. 
The administration of endotoxins (lipopolysaccharide etc.) or 
live bacteria elicits the release of proinflammatory cytokines 
(IL-1, IL-6 and TNF-α) from various immune cells, leading 
to hyperalgesia. Neurotrophic viruses such as HIV-1 (caus-
ing AIDS) can cross the blood-brain barrier and activate mi-
croglia and astrocytes. Microglia and astrocytes recognize a 
glycoprotein (gp 120) expressed on the surface of HIV-1. 
Interestingly, i.t. application of gp 120 induced mechanical 
allodynia and hyperalgesia. Thus, the importance of spinal 
cord microglia and astrocytes to hyperalgesia and allodynia 
was stressed [36]. A subcutaneous injection of formalin (5%, 
50 μl) into the hind paw of rats induced an increase of mi-
croglia and their activation on the ipsilateral side of the lum-
bar superficial dorsal horn and the gracil nucleus of the 
brainstem [37]. Cytokines, COX products, and NO released 
from activated microglia were suggested as serious inducers 
of neuropathic pain. IL-1β-dependent COX2 induction and 
PGE2 release were demonstrated in the CNS of rats injected 
with complete Freund’s adjuvant (CFA) into the hind paw 
[38]. The authors claimed that COX2 expression in the CNS 
following peripheral inflammation indicates a non-neuronal 
response, because the expression of COX2 mRNA in the 
lumbar spinal cord and PGE2 in the cerebrospinal fluid could 
not be eliminated after a complete sensory and motor con-
duction blockade of the sciatic nerve by bupivacaine [38]. 
Concomitantly, COX2 and the type-I IL-1β receptor were 
highly expressed, regardless of dorsal root rhizotomy, in 
neurons of lamina I-III of the dorsal horn ipsilateral to the 
inflamed paw [38].  
 Tight ligation of the lumbar spinal nerve induced an in-
crease of FGF-2 and FGF-2 mRNA expression in the ipsilat-
eral dorsal horn astrocytes [39]. The activated astrocytes and 
increase of FGF-2 in the dorsal horn paralleled the induction 
of mechanical allodynia 2 weeks after surgery, suggesting 
that FGF-2 is involved in the central sensitization after pe-
ripheral nerve injury [39]. Many studies have demonstrated 
that p38 MAP (mitogen activated protein) kinase is specifi-
cally activated in hyperactive microglia in neuropathic pain 
models [40]. Enhanced pain behavior was reduced by pre-
treatment with inhibitors of p38 in the same experiments 
[40]. It was demonstrated in rats that ipsilateral glial cells 
(microglia and astrocytes) in the medullary superficial dorsal 
horn (MDH, lamina I-II) were activated following inferior 
alveolar nerve and mental nerve (V3) transection (IAMNT) 
associated with hyper tactile sensitivity (stimulation of 
whisker pads with a von Frey filament) [41]. The area of 
microglial activation was the same as the area of c-fos up-
regulation [41]. Since the number of TG neurons did not 
show a decrease, the authors concluded that the glial activa-
tion is due not to degenerative effects of the central terminals 
of primary afferents caused by the death of TG neurons but 
to the release of substances from the central terminals. Mi-
nocycline (inhibitor of microglial activation) reduced pain 
hypersensitivity after trigeminal nerve transection in parallel 
with a decrease in the phosphorylation of p38 MAPK and 
microglial activation [41]. Substances released from nocicep-
tive central afferent terminals and /or MDH neurons were 
presumed to be the cause of glial activation (neuronal effects 
on central glia) [41]. It is important to note that the induced-
area of tactile hyperalgesia by IAMNT was the cutaneous 
sensory area (V2 region) of the maxillary nerve which was 
not injured in this experiment. This is very similar to the 
results of p38 activation in uninjured L4 and L5 DRG neu-
rons after L5 ventral root transection [42]. AV 411 (ibudi-
last: 3-isobutyryl l-2-isopropylpyrazole-pyridine, inactivat-
ing agent of glial cells) reduced mechanical allodynia in-
duced by CCI of sciatic nerve and SNL (tight suture of L5 
and L6 spinal nerves) in rats [43]. The efficacy of AV 411 
was closely related to the decrease in immunoreactivity for 
GFAP in the lumbar spinal dorsal horn on the operated side 
[43]. The authors proposed using AV 411 for the clinical 
regulation of chronic pain. 
 Activation of phosphorylated Src-family (p-Src family) 
tyrosine kinases was demonstrated in OX42-immunoreactive 
microglia but not neurons and astroglia in the ipsilateral su-
perficial dorsal horn after transection of the L5 spinal nerve 
in rats [44]. Src-family tyrosine kinases (SFKs) were esti-
mated as having a close correlation with mechanical hyper-
sensitivity but not thermal and cold hypersensitivity after 
spinal nerve injury, because of the alleviation of only me-
chanical hypersensitivity by 4-amino-5-7-pyrazol pyridine 
(PP2, inhibitor of SFKs) [44]. The activation of the Src fam-
ily was suggested to increase the phosphorylation (p) of ex-
tracellular-regulated protein kinase (ERK), but not p38 
MAPK (co-expression of p-ERK and p-p38: 33%) in spinal 
microglia after nerve injury [44]. Thus, Src-ERK signaling 
was argued to be involved in nerve injury-induced mechani-
cal hypersensitivity, separate from the p38 MAPK pathway. 
Curiously, selective motor fiber injury (L5 ventral root tran-
section) led to the increased activation of p38 in uninjured 
ipsilateral L4 and L5 DRG neurons, and microglia (but not 
neurons) in the bilateral spinal dorsal horn [42]. The authors 
concluded that p38 activation via TNF-α synthesis is an ini-
tial marker for the induction of neuropathic pain (mechanical 
allodynia). However, the molecular mechanism (transmitting 
signals from injured fibers to intact DRG neurons and mi-
croglia) underlying injury-induced allodynia was not demon-
strated in this study.  
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 Spinal cord injury to wild-type mice after a L5 spinal 
nerve transection induced the expression of p38, TNF-α, and 
NO synthetic enzyme (NOS) in the dorsal horn microglia, 
but failed to cause the expression of these cytokines in TLR 
(toll-like receptor) 2 knock-out mice [45]. TLR 2 on micro-
glial cells was suggested to play an important role in the ac-
tivation of nerve injury-induced p38 and the expression of 
TNF-α and NOS associated with hyperalgesia and mechani-
cal allodynia [45]. TLRs are speculated to bind to endoge-
nous molecules as well as pathogens, leading to inflamma-
tory responses by innate immune cells upon bacteria and 
viral infections. SDSN (supernatant of damaged sensory neu-
rons) extracted from F11 cells (a hybrid of mouse N18TG2 
neuroblastoma cells and rat DRG neurons) by repeated freez-
ing and thawing was used to stimulate microglial cells from 
both wild-type and TLR-knock-out mice [45]. Upon stimula-
tion with SDSN, the mRNA expression of TNF-α, IL-1β, IL-
6 and inducible NOS (iNOS) increased in the wild-type mi-
croglia, but almost completely disappeared in the knock-out 
cells. These results indicate that TLR 2 mediates the effects 
of nerve injury factors (for instance, SDSN), leading to me-
chanical allodynia and thermal hyperalgesia [45]. Not only 
DRG cell damage but also nerve fiber injury triggered mi-
croglial activation in this study. Although the chemicals of 
SDSN are not shown, unknown substances released from 
damaged neurons were predicted as important inducers of 
neuropathic pain.  
 The relationship between thermal and mechanical hyper-
algesia, and activation of spinal cord astrocytes and micro-
glia was investigated by injecting Asian scorpion Butus 
martensi Karsch (BmK) into the plantar hind paw of rats 
[46]. BmK induced thermal and bilateral mechanical hyper-
algesia and early and late activation of microglia and astro-
cytes, respectively, suggesting the share of microglia and 
astrocytes in BmK envenomation-induced pain [46]. The 
activation of microglia and astrocytes in the ipsilateral super-
ficial dorsal horn (L4-L5 spinal segment) and pain-related 
behavior were reduced by the i.t. injection of fluorocytrate or 
peritoneal injection of minocycline. From the time difference 
in activation between microglia and astrocytes, the latter was 
considered to contribute to the maintenance of bilateral me-
chanical hyperalgesia [46]. The therapeutic inhibition of glial 
activity in the spinal cord was stressed for the treatment of 
patients stung by scorpions [46].  
 The role of PNS (DRG) satellite glial cells (SGCs) in 
neuropathic pain was proposed based on recent experimental 
evidence [47]. Particularly, inhibition of glutamate recycling 
(accumulation of glutamate) in DRG cells caused by a de-
crease of glutamate transporters in the SGC after nerve in-
jury and the activation of macrophages (equivalent to CNS 
microglia) were emphasized to explain the chronic neuropa-
thy [47]. The authors recommended that pain induced by the 
activation of glia in both the PNS and CNS be termed 
“gliopathic pain”.  
3.2. Morphological Changes to Glia after Nerve Injury 
 Morphological changes of SGCs in L4 and L5 DRGs 
were reported after the transection of sciatic and saphenous 
nerves in mice, but hyperalgesic or allodynic behavior was 
not studied [48]. The formation of bridges between satellite 
cells ensheathing separate DRG cell bodies and development 
of new gap junctions were demonstrated, suggesting the in-
duction of an enhanced pain state after peripheral nerve in-
jury [48]. Dye coupling between SGCs and surrounding neu-
rons showed a 6-fold increase in mouse DRG 2 weeks after 
sciatic nerve axotomy, also suggesting the formation of new 
gap junctions [20]. The movement of dye (true blue) from 
TG neurons to adjacent SGCs through connexons of gap 
junctions was demonstrated after the injection of capsaicin 
into the temporomandibular joint [49]. Neuron-glia signaling 
within TGs was thought to contribute to the development of 
peripheral sensitization through the transmission of inflam-
matory signals, as a result of migraines [49]. 
 The mechanism of communication between neurons and 
SGCs is as yet unclear [20]. One review [50] inferred that 
astrocytes in the CNS can regulate presynaptic and postsy-
naptic maturation, including receptor density (increase or 
decrease) and the efficacy of transmitter release. Thus, the 
function of tripartite synapses, i.e., among presynaptic and 
postsynaptic neurons and astroglia, was suggested to be 
closely regulated by astrocytes [50]. 
 To detect the changes of microglia in the CNS and DRGs 
after common peroneal nerve (CPN) ligation, transgenic 
mice with all microglia labeled by green fluorescence protein 
(GFP) were used in place of immunocytochemical methods 
[51]. Tactile allodynia (von Frey filament test to the point of 
bending over the dorsal hind paw) was induced in the ipsilat-
eral hind paw following CPN injury. An increase and the 
activation of microglia (large cells with short, thick radiating 
processes) in the L4 segment were observed in the ipsilateral 
superficial dorsal horn (lamina I and outer part of lamina II) 
and ventral horn (lamina VII and IX) after CPN ligation 
[51]. Microglial activation was not seen in the CNS areas 
(anterior cingulated cortex, prefrontal cortex, primary and 
secondary somatosensory cortex, insular cortex, amygdala, 
hippocampus, periaqueductal gray, and rostral ventromedial 
medulla) following nerve injury. The contribution of micro-
glia to chronic neuropathic pain is suggested to be related to 
that of spinal dorsal horn [51]. The authors speculated that 
microglia in the dorsal horn are activated by spontaneous 
excitatory signals from injured nerves rather than abnormal 
neuronal activity through injured nerve fibers [51]. A change 
of neither morphology nor density was found in the glial 
cells of the L4 DRG [51].  
3.3. Controversial Issues Regarding the Role of Glia in 
Neuropathic Pain 
 Cannabinoids are known to inhibit pain through cannabi-
noid receptor-1 (CB1) located in the superficial dorsal horn. 
Strong CB1-immunoreactivity was demonstrated in lamia I 
and inner lamina II interneurons and astroglial processes 
other than pre- and postaxonal terminals of the dorsal horn, 
and smaller DRG neurons [52]. Therefore, astroglia were 
suggested to have an anti-hyperalgesic function [52]. In ad-
dition, McMahon et al., drew attention to controversy re-
garding inflammatory pain with microglial activation [40].  
 The causal relationship between mechanical (response to 
a single safety-pin prick to the plantar hind paw) and thermal 
pain behavior (applying acetone onto the plantar skin of the 
hind paw), and the density of primary afferent terminals, 
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GABA-ir interneurons and astrocytes in the injured side spi-
nal dorsal horn of rats were studied after partial or total tibial 
nerve ligation (TNL) [53]. The behavior was more severe 
after a partial TNL than total TNL. Numbers of SP-, CGRP-, 
and isolectin B4 (IB4)-positive fibers were reduced in the 
medial superficial layer (tibial zone) compared with the con-
trol after tibial nerve injury [53]. The number of activated 
astrocytes in the injured dorsal horn did not differ signifi-
cantly between partial TNL vs. total TNL, and in TNL rats 
with or without pain behavior [53]. The decrease in the 
number and density of central primary afferent terminals and 
GABAergic interneurons, and the increase of GFAP-ir astro-
cytes and activated astrocytes were not associated with pain 
behavior. These results suggest that the increase of astro-
cytes and decrease of GABA-ir interneurons in the dorsal 
horn 7 days after injury is not necessarily correlated with 
mechanical allodynia [53]. 
 A long-lasting increase of synaptic strength in spinal cord 
neurons (long-term potentiation: LTP) induced by high fre-
quency stimulation (HFS) to the sciatic nerve was suggested 
to be related to the exaggerated pain behavior of the rats 
[54]. A significant increase in mRNA for IL-1β, GDNF and 
iNOS in the lumbar ipsilateral spinal dorsal horn was dem-
onstrated, although there was no significant increase in p38 
MAPK, COX2 or TNF-α after HFS [54]. In contrast to pre-
vious reports [34, 37, 38, 41, 42, 45], the gene expression of 
p38 MAPK, COX2 and TNF-α did not seem to be important 
for spinal LTP by HFS [54].  
 The mechanisms of neuronal-glial communication and of 
the release of ATP, glutamate and other chemical messen-
gers from glia in response to pathophysiological stimuli are 
yet to be defined [55]. Repetitive afferent inputs (caused by 
peripheral injury) increase the release of excitatory amino 
acids (glutamate) and peptides (SP or CGRP) from primary 
afferent terminals in the superficial dorsal horn, inducing the 
initial depolarization of dorsal horn neurons [32]. Sustained 
excitation serves to increase intracellular calcium levels, 
activating a variety of intracellular enzymes (COX2 and 
NOS) and PKC. Spinally released PGs and NO acutely en-
hance the subsequent release of afferent neuropeptides and 
glutamate. The activation of local kinases serves to phos-
phorylate membrane receptors and channels. Thus, Yaksh et 
al. [56] emphasized the sensitization of central terminals of 
C-fibers in the substantia gelatinosa of the dorsal horn as the 
key to hyperalgesia and allodynia induced by peripheral 
nerve injury, but did not refer to the role of CNS glia. In a 
recent report [57], the function of agrin (a single gene-
encoded sulfate proteoglycan which gather up various mole-
cules ensuing specific functions) suppressing neuropathic 
pain (mechanical allodynia) through phosphorylation of the 
NMDA receptor (NR1 subunits) on GABA interneurons of 
the rat dorsal horn was demonstrated after sciatic nerve in-
jury. Activation of GABA interneurons by NR1 phosphory-
lation was argued to inactivate the postsynaptic relaying neu-
rons, consequently interrupting the pain. Unexpectedly, a 
decrease of the activation of glia did not suppress the allo-
dynia [57].  
 Whether electrical or chemical transmission occurs in 
tripartite synapses is not clear at least in brain astrocytes 
[58]. As noted above, some results are controversial, with 
lines of evidence that glia and immune cells apparently affect 
neuropathic pain in the nervous system.  
 Both non-specific and specific (recognition of non-self 
substance) local immune responses to tissue damage, infec-
tion, or irritants cause inflammation [59]. The immune sys-
tem ultimately initiates hyperalgesia, a ubiquitous form of 
defense against disease, in the vicinity of an injury [59]. The 
intraperitoneal administration of disease-inducing factors 
(pro-inflammatory cytokines, bacterial cell wall, killed bac-
teria, zymosan (yeast), tissue damage etc.) is able to generate 
hyperalgesia [59]. It is reasonable to think that hyperalgesia 
is a warning sign for protecting an injury from endogenous 
or exogenous attack to restore energy, mobilizing vital im-
mune and nervous systems [59]. Therefore, inflammatory 
pain has a close correlation between the immune system and 
peripheral or central sensory systems.  
4. A PART OF TRP CHANNELS IN PATHOLOGICAL 
PAIN 
 This section mainly deals with the receptors of 3 kinds of 
thermo TRP channels (TRPV1, TRPA1 and TRPM8) and 
intracellular pathways leading to produce the pathological 
pain. 
4.1. Capsaicin Receptor, TRPV1, and Neuropathic Pain 
 The capsaicin receptor TRPV1 (transient receptor poten-
tial vanilloid 1), an ion channel, is the central generator of 
hyperalgesia [60] and an integrator of endogenous and ex-
ogenous signals [61]. Its regulatory mechanisms in intracel-
lular signaling are complicated [61]. TRPV1 is a multimodal 
nocisensor able to sense heat, low pH (protons), and internal 
as well as external vanilloids [61] and allosterically modu-
lated by pro-inflammatory mediators (PG, BK, ATP, 5-HT, 
NGF), enhancing the channel opening by heat, protons and 
capsaicin [60]. A pH lower than 6.4 (acidification) [62, 63] 
or higher than 8.0 (intracellular alkalization by NH4Cl) [64] 
initiates tissue inflammatory conditions, lowering the thresh-
old of TRPV1 to noxious stimuli. TRPV1-expressing periph-
eral terminals release various pro-inflammatory neuropep-
tides such as SP and CGRP, initiating neurogenic inflamma-
tion (vasodilation, plasmaextravasation) [13, 65, 66].  
 Despite a profound loss of VR1 (former name of the cap-
saicin receptor TRPV1)-expressing C-fibers, capsaicin-
induced biting-licking behavior reappeared in mice with 
streptozotocin (STZ)-induced diabetes treated with capsaicin 
as neonates [67]. Surprisingly, capsaicin-insensitive A-fibers 
(large DRG neurons) expressed the capsaicin receptor VR1 
in diabetic mice [67]. The authors considered that up-
regulation of VR1 expression on myelinated fibers accounts 
for the antihyperalgesic (analgesic) action of capsaicin cream 
in diabetic neuropathic pain [67]. By contrast, TRPV1-
positive nerve fibers showed a decrease in both sural nerve 
and skin biopsies from patients with painful diabetic neu-
ropathies, implying no relation of TRPV1 to neuropathic 
pain [68]. 
 Sensitization to TRPV1 by pro-inflammatory mediators 
(inflammatory soup) is believed to induce chronic pain 
(thermal hyperalgesia or allodynia) from normally innocuous 
stimuli [69, 70]. TRPV1 null (deficient) animals have 
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showed a dramatic reduction of thermal hypersensitivity 
(hypoalgesia) in inflammatory pain models [69, 71], but not 
in nerve-injury models [69]. The TRPV1null animals also 
behaved normally in response to innocuous and noxious me-
chanical stimuli [69, 71]. From these findings, TRPV1 can 
potentiate a heat response under inflammatory conditions 
(low pH), but does not function in response to thermal and 
mechanical stimuli in the case of injury [69].  
 Paradoxically, TRPV1 null mice showed normal re-
sponses to acute noxious heat [72-74]. Similarly, mice pre-
treated with capsaicin as neonates behaved normally when 
exposed to acute noxious heat [75-77]. Therefore, an acute 
noxious heat sensor other than TRPV1 was speculated to 
exist in primary afferent neurons [78, 79].  
 The larvae of mutant Drosophila painless flies showed a 
delayed response (hypoalgesia) to noxious heat (48 ℃), but a 
rapid response to temperatures above 52 ℃ similar to normal 
larvae [80]. The painless gene encodes a TRP ion channel. 
The authors hypothesized that TRP ion channels act as a 
common noxious heat sensor in both vertebrates and inverte-
brates, in other words “Nociception is to pain as phototrans-
duction is to vision” [80], and “a separate pathway exists for 
moderate and intense noxious heat”[80]. 
4.2. The Actions of Agonists and Antagonists to TRPV1 
 It was reported that both capsaicin and protons gate the 
TRPV1 channel [81]. Protons (low pH) potentiate the bind-
ing of capsaicin and promote opening of the channel, proba-
bly by binding directly to the open channel rather than cap-
saicin-binding sites [81]. A functional antagonist, ruthenium 
red (RR, TRPV1 channel blocker), failed to block noxious 
heat- and proton-induced firing but inhibited capsaicin’s 
actions (sensitization to other noxious stimuli) in a study of 
ex-vivo saphenous nerve preparations of rats [62]; RR was 
able to prevent capsaicin’s actions but not acute noxious 
heat. RR seems to bind the capsaicin-binding site but not 
interfere with proton binding, so it can not inhibit the firing 
induced by acidification. Thus, RR’s inability to interfere 
with normal basal heat transduction is very similar to the 
behavior of TRPV1-deficient mice with no impairment of 
noxious heat sensitivity [62, 82].  
 Inflammatory mediators such as BK, 5-HT and PGE2 
induced sensitization (an inward membrane current) of cul-
tured capsaicin-sensitive DRG neurons from newborn rats in 
acidic conditions (pH6.1) [83]. Since capsazepine (CPZ), an 
antagonist of capsaicin, inhibited such sensitization, it was 
suggested that the capsaicin receptor can function under in-
flammatory conditions [84]. The authors also implied that 
capsaicin and protons can gate the channel pore acting at the 
two different recognition sites on the same receptor protein 
[84]. CPZ reduced the hyperalgesic response (decrease in 
latency of hind paw’s withdrawal in response to heat) caused 
by the pro-inflammatory mediator carrageenan without inhi-
bition of paw edema. This indicates that the capsaicin recep-
tor can function only in the nociceptive response underlying 
the presence of endogenous capsaicin-like ligands, but not in 
the effects of pro-inflammatory cells [84]; TRPV1 is not 
activated via inflammatory cells. CPZ competitively antago-
nized capsaicin’s action but did not inhibit the action of pro-
tons, a candidate of an endogenous activator [84].  
 It was speculated that CPZ binds the vanilloid-binding 
pocket located in the TM (transmembrane) 3/4 region of the 
channel but does not induce allosteric change, and so does 
not block Ca2+ entry through the pore stimulated by low pH 
(5.0) [85]. Additionally, CPZ antagonizes nicotinic and volt-
age-gated calcium channels, i.e., it is not strictly selective of 
TRPV1 [86, 87]. Thus, the action of CPZ to TRPV1 is con-
troversial: one, CPZ inhibits inflammation through TRPV1, 
while the other does not.  
 Acs et al., [88, 89] suggested the presence of two types 
of vanilloid receptor, i.e., high-affinity RTX (resiniferatoxin) 
binding (R-type) and low-affinity RTX binding (C-type). 
The discrepancy in normal response behavior to thermal 
noxious heat in TRPV1 null animals may be explained by 
the two distinct receptors. However, Szallasi and Blumberg 
[90] questioned such a notion, because the presumed two 
receptors seemed to show the mediation of either high-
affinity RTX binding or low-affinity calcium uptake re-
sponse in experiments using HEK293 cells transfected with 
VR1 cDNA. The activation of TRPV1 by ligands lowers the 
temperature threshold (hyperalgesia to heat), but the mecha-
nisms of heat sensitivity are not clear [91]. It is worth keep-
ing in mind that no selective inhibition of heat activation has 
been found in mutational studies [91, 92]. 
 New TRPV1 antagonists (change of certain chemical 
radicals in CPZ) which effectively block the activation by 
capsaicin, protons and heat were reported to show more po-
tent antagonism, have high specificity, and be competitive 
antagonists [93]. Wong and Gavva [93] classified TRPV1 
antagonists into 4 categories (profile A to D) in which profile 
A antagonists block all modes of TRPV1 activation (capsai-
cin, pH 5, heat). Profile D antagonists block activation by 
capsaicin, but in contrast potentiate the activation by both pH 
5 and heat [93]. They demonstrated that profile A antago-
nists such as A-425619, AMG9810 and BCTC inhibited or 
reduced inflammation-induced hyperalgesia in rats, implying 
that the inhibition of all modes of TRPV1 activation is cru-
cial for anti-hyperalgesia [69, 93]. CPZ is classified in pro-
file B because it blocks capsaicin and heat activation but not 
proton activation in rat TRPV1, and so can not antagonize 
inflammatory pain [93]. The different actions of each an-
tagonist have attracted our considerable interest. 
 Despite that TRPV1 agonists such as the ultrapotent va-
nilloid RTX relieve pain through TRPV1 desensitization, 
they also induce nociceptive neuronal cell death, and so 
TRPV1 antagonists are potentially better drug candidates for 
pain treatment [93]. Quite recently, different clinical applica-
tions of vanilloid agonists for anti-nociceptive, anti-
inflammatory and anti-hyperalgesic effects via TRPV1 
channels have been reported [94, 95].  
4.3. Sites of Action in the Molecular Structure of TRPV1 
and TRP Complex in Modulating its Activity 
 The amino acid residue aspartic acid (D) 646 in the pore 
region of TRPV1 was implicated as the binding site for RR 
due to the blocking of capsaicin’s action [96]. Glutamic acid 
(E) 600 in the pore region was demonstrated as an important 
site generating a dynamic increase in heat-evoked current 
between pH 8 and 6 [97] as well as responding to the thermal 
threshold above 43℃. The TM6 inner-pore helix domain of 
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TRPV1 [tyrosine(Y) 666-glycine (G) 683; particularly, 
threonine (T) 670 and alanine (A) 680] was suggested as a 
site of temperature-sensitive bending hinges [98]. The point 
mutation E648A in the extracellular region of oocytes 
showed a greater decrease in proton-activated current but not 
in capsaicin- or heat-evoked current, suggesting it to be a 
proton-mediated activation site [97]. The Y511A mutant in 
the cytosolic region near the TM 3 domain of the TRPV1 
protein showed normal heat- and proton-evoked responses 
comparable to the wild type, although lacking significant 
capsaicin-sensitivity: the aromatic residue Y511 is critical 
for vanilloid-binding with the vanillyl moiety of capsaicin in 
rat and human TRPV1[61, 92, 99, 100]. Furthermore, Y511, 
methionine (M) 547, and T550 may be important molecular 
determinants of vanilloid-sensitivity [100]. Many TRPV1 
agonists and antagonists are believed to bind overlapping 
sites, the so called vanilloid binding-pocket, within the 
TM3/4 region, but a few TRPV1 inhibitors such as RR bind 
to residues within the pore region (D646) [69, 96]. It was 
speculated that high extracellular concentrations of poly-
amines (spermine) at inflammatory sites could sensitize and 
permeate TRPV1 ion channels, indicating the important role 
of the pore region (D646 and E648) [101]. Recently the 
critical role of TRPV1 pore region was stressed for the spe-
cies differences in block of the TRPV1 heat activation [102]. 
 The signaling complex “transducisome” (TRP complex) 
derived from the Drosophila phototransduction machinery 
[103], which contains the TRP protein, scaffolding proteins 
such as PDZ (postsynaptic density protein, disc-large tumor 
suppressor, zonula occuludens protein) domains, receptors 
(Trk A, Trk B), enzymes (PLC, PKC) and PIP2, is very im-
portant to the TRP channel’s function [102, 103]. Both 
phosphorylation of TRPV1 and hydrolysis of PIP2 (removal 
from membranes) lower the heat threshold (hyperalgesia) 
[104]. Serine (S) 116, T144, T370 and S502 are PKA-
mediated phopsphorylation sites [91]. PKC-mediated and 
CaMKII (Ca2+-calmodulin-dependent kinase)-mediated 
phosphorylation sites are S502 and S800, and S502 and 
T704, respectively [91]. S502 can be phosphorylated by all 
three kinases, representing a key residue in the excitation of 
sensory neurons [60]. Residues of TRPV1 detecting heat and 
modulating the heat threshold are likely spread within the 
channel [104].  
 There are three possible intracellular pathways to sensi-
tize TRPV1 [105]: 1) promotion of TRPV1 phosphorylation 
by PKCε through activation of bradykinin receptors (B1, B2) 
by bradykinin; 2) activation of TRPV1 via inactivation of 
PIP2 (hydrolysis) by PLCβ (however, there is controversy 
over recovery from desensitization or potentiation of TRPV1 
by PIP2) [106-108]; and 3) NGF’s potentiation of TRPV1 via 
activation of PI3K (phosphoinositide 3-kinase) and tyrosine 
kinase Src, allowing phosphorylation of TRPV1 at Y200 and 
trafficking TRPV1 to the plasma membrane of the nocicep-
tive neuron [107].  
 The scaffold protein AKAP (A kinase-anchoring protein) 
is known to target PKA, PKC and Ca2+-dependent phos-
phatase calcineurin on substrates [105]. The binding of PKA 
and PKCε to AKAP79 (human homolog)/150 (rat homolog), 
and in turn the binding of AKAP79/150 to the amino acid 
residues near the C-terminal domain of the channel is 
thought to be crucial for the sensitization of TRPV1 [105]. In 
addition, AKAP150 was demonstrated as a major PKA-
anchoring protein participating in PGE2- and PKA-
dependent TRPV1 modulation in mouse DRG neurons [109]. 
Moreover, it was demonstrated that AKAP coupled with 
PIP2 released from plasma membranes by PLC activation 
associate with TRPV1 in cell cultures of both chinese ham-
ster ovary (CHO) cells and trigeminal sensory neurons, and 
so regulating phosphorylation and sensitization of TRPV1 
[110]. Namely, PLC-mediated sensitization of TRPV1 is 
dependent on AKAP150. The major mechanisms responsible 
for nociceptor sensitization can be summarized as follows 
[111]: 1) chemical modification of intracellular domains of 
TRPV1 by PK or phosphatases, and /or by hydrolysis of 
phosphoinositides contributes to greater channel activity, 
leading to sensitization, and 2) enhancement of TRPV1 ex-
pression in peripheral (or central) terminals of primary affer-
ent neurons causes hyperalgesia. 
 For the induction of central sensitization in the substantia 
gelatinosa of the spinal dorsal horn, membrane-delimited 
coupling of TRPV1 with metabotropic glutamate receptor 5 
(mGluR5) on the central presynaptic terminals of nocicep-
tive neurons was suggested to have an important role associ-
ated with chronic pain [112]. 
 Direct or indirect regulation of TRPV1 by endogenous 
factors was concisely reviewed by Marzo et al., [113]. PKA 
and PKC potentiate the gating of capsaicin receptors by nox-
ious heat, protons (inflammatory condition), vanilloids and 
endovanilloid “anadamide (arachidonylethanolamide, AEA)” 
[113]. The thermal sensitivity of TRPV1 and capsaicin-
evoked response were reduced by PIP2, suggesting that en-
dogeneous PIP2 modulates (inhibits) TRPV1 and that hy-
drolysis of PIP2 by PLC restores the actions of TRPV1 
[114]; it was demonstrated that intracellular PLC signaling 
has a pivotal role in the hyperalgesia induced by two algesic 
agents, bradykinin and NGF [114]. The carboxy-terminal 
region near the proximal C-terminal domain is known to 
interact with both PIP2 and calmodulin, indicating negative 
regulation (inactivation) of TRPV1 [115]. In contrast, dual 
effects of phosphoinositides [PIP2 or phosphatidylinositol-4-
phosphate: PIP] on TRPV1 were found depending on the 
stimulative force [116]; at a high concentration of capsaicin, 
phosphoinositides activate TRPV1 channels, and have no 
inhibitory effects, but at a low concentration of capsaicin or 
after a mild increase in temperature, they induce both inhibi-
tion and activation of the channels [116]. Phosphorylation of 
TRPV1 (activation) by PKA is emphasized for induction of 
heat hyperalgesia under inflammatory conditions [115]. 
Modulation of sensitivity in peripheral nociceptors via inter-
action between the SP receptor’s neurokinin-1 (NK-1) and 
TRPV1 requiring PLCβ and PKCε (but not PKA) can lead to 
heat hyperalgesia being exaggerated after inflammation 
[117]. NK-1 activation leads to membrane trafficking of 
PKCε, resulting in the potentiation of TRPV1 activity 
[117]. 
 Despite the profound loss of L4 DRG small neurons and 
dorsal root unmyelinated fibers in mice treated with capsai-
cin as neonates (2 and 5 days of life), the animals behaved 
normally in response to noxious heat (hot plate: 55℃, radi-
ant heat) [75, 76], suggesting the presence of an unknown 
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sensor beside capsaicin-sensitive, TRPV1-expressing DRG 
neurons in mice [77-79]. In this regard, recently it was re-
ported that TRPV2 knockout or TRPV1/TRPV2 double 
knockout mice behaved normally to a broad range of nox-
ious heat (48-58 ℃) even though in the peripheral inflamma-
tory conditions [118]. TRPV2 expressed in medium- to large 
sized primary sensory neurons has long been believed to be 
activated by high threshold heat (> 52 ℃), however, it is not 
essential for heat and mechanical nociception [118].  
4.4. A putative Cold Sensor of TRP Channels, TRPA1, 
and Inflammatory Pain 
 Initially, TRPA1 (transient receptor potential ankyrin 1, 
formerly known as “ANKTM1”) was identified as the trans-
formation-sensitive protein p120 extracted from cultured 
fibroblasts, which represents a novel TRP-like molecule with 
18 ankyrine repeats in the N-terminal region within the cyto-
plasm and 6 transmembrane domains [119, 120]. Since 
TRPA1 is a nociceptive-specific ion channel gated by irri-
tants and endogenous proinflammatory mediators, its inacti-
vation would provide a new strategy for the treatment of 
coughing as well as inactivation of TRPV1 [121]. Cinnamal-
dehyde (CA, most specific TRPA1 agonist, ingredient of 
cinnamon oil) and BK could activate TRPA1, implying that 
TRPA1 is a polymodal nociceptor involved in BK-induced 
excitation, and in perceiving the burning pain sensation of 
cold [122]. Thus, TRPA1 has been thought to be required for 
the induction of neurogenic inflammation and pain hyper-
sensitivity due to the activation of TRPA1 by BK, but not 
required for the initial detection of acute cold and auditory-
sensitivity [123]. Indeed, TRPA1-deficient mice showed 
reduced sensitivity to mustard oil and BK as well as to in-
tense cold (0 ℃) and mechanical stimuli, therefore the con-
tribution of TRPA1 to the sensing of acute cold and auditory 
stimulation remained to be elucidated [123]. The expression 
of TRPA1 was detected in the stereocilia of mouse inner and 
outer hair cells, suggesting its role as a mechanoreceptor and 
mechanonociceptor [124].  
 TRPA1 was found in a subset of small sensory neurons 
which also express TRPV1 (97% ANKTM1-positive rat 
DRG neurons: TRPV1-positive) and the inflammatory pep-
tide CGRP (97% TRPA1-positive neurons: CGRP-positive) 
[120]. The proportion of TRPA1-expressing neurons was 
56.5%, 36.5% and 28.4% in the adult mouse DRG, trigemi-
nal ganglia and nodose ganglia, respectively, highly re-
stricted to the smaller nociceptive neurons [125]. Up-
regulation of TRPA1 expression (ipsilateral: 29.5%, contra-
lateral: 17.2%) was demonstrated in the ipsilateral L4 DRG 
neurons of rats after L5, L6 spinal nerve ligation (SNL) 
[125]. In parallel with the up-regulation of TRPA1 expres-
sion in a population of Aδ-fibers, SNL-induced mechanical 
(von Frey) and cold (6 ℃) hyperalgesia were found in SNL 
rats [126]. Thus, TRPA1-expressing small DRG neurons and 
peripheral Aδ-fibers are considered to be responsible for 
mechanical and cold allodynia. 
 TRPA1 exhibited a lower activation temperature (mean: 
17.5 ℃) than TRPM8 (transient receptor potential melastatin 
8, mean: 22.5 ℃), implying it to be a sensor for nociceptive 
cold [120]. Most allyl isothiocyanate (AITC: a TRPA1 ago-
nist, the ingredient of mustard oil)-sensitive (TRPA1-
expressing) mouse DRG neurons and mouse TRPA1-
expressing HEK293 cells responded to deep cooling (5-18 
℃) [127]. The probability of the TRPA1 channel opening 
increased when the temperature decreased below 18 ℃, fol-
lowed by an increase in whole-cell current induced by no-
ciceptive cooling [127]. Conversely, TRPA1 was activated 
by mustard oil and tetrahydrocannabinoid (THC: cannabi-
noid receptor agonist), but not by noxious cold in cultured 
rat trigeminal neurons and TRPA1-expressing HEK293 
cells, indicating its insensitivity to noxious cold [125, 128]. 
An interesting candidate for a cold nociceptor, TRPA1, was 
also activated by alkalization [129], although, the alkaliza-
tion was suggested to induce acute pain rather than inflam-
mation or hypersensitivity [129]. The injection of 15d-PGJ2 
(15-deoxy-Δ12, 14-prostaglandin J2, a cyclopentane PGD2 
metabolite) into the hind paw of wild-type and TRPA1-
deficient mice induced and failed to induce robust and acute 
nociceptive behavior, respectively [130]. These findings in-
dicated that 15d-PGJ2 induced peripheral nociception 
through TRPA1, showing that TRPA1 is the principal recep-
tor of 15d-PGJ2 in pain-sensing DRG neurons [130]. The 
expression of TRPA1 mRNA in GFRα3 (glycosylphosphati-
dylinositol anchored protein; binding protein for artemin, a 
neuronal survival factor in the GDNF family) -positive DRG 
neurons of ART-OE mice (transgenic overexpressing ar-
temin in skin keratinocyte) was augmented in accordance 
with the increase of sensitivity to both heat and noxious cold 
[131]. The authors tentatively concluded that TRPA1 has an 
important role in the sensing of noxious cold and in nocicep-
tive processing after inflammation [131]. Increased sensitiv-
ity to heat and mechanical stimuli was seen in both TRPA1-/- 
and TRPA1+/+ mice [132]. These studies indicated that al-
though 4-HNE [4-hydroxynonenal as α, β-unsaturated hy-
droxyalkenal (a product of lipid peroxidation accumulating 
in membranes under conditions of inflammatory and oxida-
tive stress)] -induced cold allodynia is dependent on a func-
tional TRPA1, but heathyperalgesia and mechanical allo-
dynia are not [132]. As a consequence, the role of TRPA1 in 
cold allodynia was demonstrated in murine models of in-
flammatory and neuropathic pain [133].  
 CHO cells expressing human and rat TRPA1 were acti-
vated (Ca 2+-uptake assay) by AITC and cold (3.5 ℃) and 
inhibited by RR [134]. TCEB [trichrolo(sulfanyl)ethyl ben-
zamides] compounds functioned as antagonists of TRPA1’s 
activation by noxious cold and AITC [134]. AITC’s induc-
tion of a consistent nociceptive response via the activation of 
TRPA1 was confirmed by a behavioral study in mice, and 
dependent on capsaicin-sensitive fibers, the release of hista-
mine by mast cells and participation of tachykinine via neu-
rokinin 1 (NK1) receptors [135]. A tachykinin, substance P, 
was suggested to activate both TRPV1 and TRPA1 receptors 
and thereby produce nociception [135]. Regardless of differ-
ences in chemical structure, several noxious substances 
(AITC, CA, etc.) operate via a common mechanism, the co-
valent attachment to specific cysteine residues in the long 
cytoplasmic N-terminal domain of the TRPA1 channel 
[136].  
 It was reported that robust cold responses can occur in 
mouse DRG neurons from embryonic day 14.5 before the 
beginning of TRPM8 and TRPA1 expression, and CA-
sensitive cold (5 ℃)-responding neurons are few in number, 
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suggesting an undefined role of TRPA1 in cold perception 
[137]. The hypothesis that TRPA1 is a cold transducer was 
not supported by experiments in which an agonist, CA, and 
antagonist, RR, were applied to the skin of anaesthetized rats 
[138]. Moreover, Reid [139] questioned the role of TRPA1 
as a noxious cold sensor in vivo, implying that its responses 
to painful cold are likely to depend on sensitization. An in-
crease of TRPV1 and TRPA1 expression in undamaged L4 
DRG neurons was seen after L5 spinal nerve transection in 
the rat [44]. Since PP2 (inhibitor of SFKs) did not decrease 
the expression of TRPV1 and TRPA1 in L4 DRG, and heat 
and cold hypersensitivity after spinal nerve injury, respec-
tively, SFKs are unlikely involved in the increase of TRPV1 
and TRPA1 expression [44]. Accordingly, TRPV1 and 
TRPA1 probably do not participate in the hypersensitivity to 
cold and heat, but the activation of p-SFKs in microglia in 
the superficial dorsal horn ipsilateral to the L5 spinal nerve 
injury was suggested [44].  
 Extracellular signal-regulated protein kinase (ERK) and 
p38MAPK (family members of mitogen activated protein 
kinase) were differentially expressed in a subset of small to 
medium-sized rat DRG neurons [140]. Phosphorylation of 
ERK and p38 was found after noxious cold stimulation at 
4℃ in DRG neurons expressing either TRPA1 or TRPM8 
mRNA, although, TRPA1 was mainly expressed in p38-
labeled neurons and TRPM8 expression was favored in ERK 
labeled neurons [140], indicating the different functional 
roles of TRPA1 and TRPM8 in sensing noxious cold [140]. 
4-HNE and formaldehyde were found to be potent activators 
of TRPA1 [141]. TRPA1-deficient mice showed an impair-
ment of the stimulation by these chemicals and noxious cold 
[141]. The evidence that mice pretreated neonatally with 
capsaicin did not show behavioral change (normal response) 
to painful cold (1~2 ℃) compared with the control mice 
might indicate the pivotal role of TRPA1-expressing DRG 
neurons [142].  
 From the effects of exogenous (formaldehyde) and en-
dogenous (4-HNE) molecules on TRPA1 channels, TRPA1 
was suggested to act as a “hub nociceptor” [143]. The injec-
tion of HNE into the hind paw of mice or rats induced pain-
related behavior (licking or lifting the paw) and tactile allo-
dynia [132]. Since these responses were not changed by CPZ 
treatment, the participation of TRPV1 was not considered in 
HNE-induced pain behavior [132]. Thus, TRPA1 is believed 
to be responsible for inflammatory pain via a distinct path-
way from the TRPV1 channel. Mechanisms involved in in-
flammatory pain were suggested to be the result of the co-
activation of multiple receptors [144]. For example, antago-
nists of either TRPA1 or H1 (histamine 1) or 5-HT (sero-
tonin) receptors may be able to block formalin-induced no-
ciception [144]. The co-expression of thermoreceptors (po-
lymodal), TRPA1 with TRPV1, TRPM8 and tetrodotoxin 
(TTX)-resistant sodium channel Nav1.8 (known as nocicep-
tors) channels in rat dental trigeminal afferent neurons sug-
gested the transduction of tooth pain irrespective of hot or 
cold stimuli [145]. TRPA1, as one of the polymodal nocicep-
tors, and its activation by proalgesic and possible intense 
cold, may play a crucial role in molecular integrating for 
noxious stimuli [86]. 
 Variability of N-terminal with reducing ancestral thermo-
sensibility for the specialized noxious chemical property of 
TRPA1 was thought to be necessary in the latest report 
[146]. 
 Five factors are raised to estimate the above inconsistent 
experimental results and conclusions in understanding the 
physiological role of TRPA1 [147]; 1) Environmental differ-
ences between heterologus cells and naïve primary sensory 
neurons. 2) Differences of physiological relevance between 
sensory terminals and soma membrane channel expression. 
3) Differences in physiological properties of TRPA1-
expressing cells from injured or inflamed tissue and intact 
areas. 4) Dissociated neurons may be injured during removal 
(axotomy). 5) Participation of different components in the 
response between single cells (in vitro) and animals (in vivo).  
4.5. Another Thermosensor, the TRPM8 Channel, as a 
Nocisensor 
 For the first time, a novel trp-p8 gene was identified and 
cloned by screening a prostate-specific subtracted DNA li-
brary [148]. Trp-p8 expression in human tissue is predomi-
nantly restricted to prostate epithelial cells, with over-
expression in prostate cancer [148]. It also showed homol-
ogy to human melastatin, a trp family protein expressed in 
melanocytes [148].  
 TRPM8 (a member of the melastatin subfamily) was 
found to be a cold- and menthol-sensitive receptor (CMR1) 
belonging to the long TRP channel subfamily [149]. Like 
TRPV1 neurons, small diameter trigeminal or DRG neurons 
of rats expressed CMR1 (~50% of CMR1-expressing small 
cells: TRPV1-expressing cells) [149]. Therefore, CMR1-
expressing small sensory neurons were called “cold- and 
heat-sensitive nociceptors” [149]. At the same time, TRPM8, 
a group of TRPs characterized by a lack of ankyrin domains 
in the N terminus, was first named by Peier et al., [150] 
based on the suggestion that TRPM8 mediates Ca2+-
dependent, receptor-mediated excitation (pain signaling) and 
cell cycle progression [151]. It was reported that TRPM8 is a 
voltage-dependent channel (like TRPV1) activated by mem-
brane depolarization and the cold sensitivity of TRPM8 is 
enhanced by low doses of menthol (30μM) independent of 
temperature (24 ℃, 34 ℃) [152].  
 The first characterization of two distinct subpopulations 
of cold-responsive primary sensory neurons from adult rat 
trigeminal ganglia was made by Thut et al., [153]; one popu-
lation comprises low threshold (LT, >25 ℃) cold-responsive 
neurons (cool fibers) and the other, high threshold (HT, <25 
℃) cold-responsive neurons (C-cold nociceptors). TRPM8 
was suggested to contribute to the cooling-induced activation 
of LT neurons, because LT neurons are similar to TRPM8-
expressing neurons in percentage (12.3%), small cell diame-
ter, activation threshold, capsaicin-insensitivity and respon-
sibility to menthol [153]. On the other hand, HT neurons 
were thought to be activated by TRPM8 independently, be-
cause of an absence of menthol-sensitivity [153]. Likewise, 
HT cold (20.3±0.8 ℃)-responsive neurons (in vitro) from rat 
trigeminal ganglia detected nociceptive cold via a TRPM8-
independent mechanism (TRPM8 expression: 9.4%, menthol 
sensitive: 50%), whereas LT neurons (29.0±1.0 ℃) sense  
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cold dependent on TRPM8 (TRPM8 expression: 40%, men-
thol sensitive: 70.8%), suggesting the presence of two dis-
tinct populations of cold-responsive neurons in vivo [154]. A 
menthol-sensitive, TRPM8 cold-responsive receptor (18±1 
℃, average threshold: 26.5±0.7 ℃) determined by the spe-
cific blocking of its activation with BCTC [N-(4-tert-
butylphenyl)-4-(3-chloropyridin-2-yl) piperazine-1-carboxia-
mide], was seen in neuronal soma of the mouse trigeminal 
ganglion and guinea pig corneal nerve terminals [155]. 
 TRPM8 is specifically expressed in a subset (5-10%) of 
small neurons of the adult mouse DRG, but not co-expressed 
with TPV1 [150]. It is activated by cold (7-13 ℃) and men-
thol (mimic the threshold temperature lowering), and distinct 
from the heat- and pain-sensing neurons expressing TRPV1, 
CGRP, and IB4 [150]. In contrast, major menthol-sensitive 
cells showed capsaicin-sensitivity (co-expression of menthol 
and capsaicin sensitivity) in the cultured rat DRG neuron 
[149, 156, 157] even under conditions lacking NGF [155]. 
The authors explained the cold allodynia by suggesting the 
ectopic expression of cold sensitivity preferentially through 
TRPM8 in capsaicin-sensitive receptors. Moreover, noxious 
heat (>44±0.35 ℃) excited 65.1% of cooling-sensitive cells 
(menthol-sensitive, TRPM8-expressing cells) in the cultured 
DRG neurons of the rat [158]. That is, heat-activated TRPV1 
excited cold-sensitive (18 ℃) cells identified by Ca2+ imag-
ing and co-localization of TRPV1 in 29% of TRPM8 cells by 
in situ hybridization. Okazawa et al., [158] explained the 
paradoxical cold sensation (noxious heat above ~45 ℃-
induced cooling) by the presence of cooling-/heat-sensitive 
small diameter primary afferent neurons.  
 Intriguingly, the hydrolysis of PIP2 via PLC activation 
leads to the down-regulation of TRPM8 expression by 
dephosphorylation but up-regulation of TRPV1 expression, 
suggesting the aggravation of inflammatory pain [159]. Al-
though molecular mechanisms of the gating of thermo-TRP 
channels has not been precisely known to date, the modula-
tory role of the C terminal domain for the activation thresh-
old on the channel open of TRPM8 and TRPV1 was demon-
strated [160]. From studies of the exchange (chimeric chan-
nels) of the entire C-terminal domain between rat TRPV1 
(heat receptor) and rat TRPM8 (cold receptor) using HEK-
293 cells, the C-terminal region of thermo TRP channels was 
stressed as a determinant (modulator) of temperature pheno-
type [70, 160]. In addition, loss or single point mutation of 
the C-terminal coiled-coil domain distal to the last TM6 do-
main diminishes or depletes TRPM8’s action [161].  
 Group I mGluR antagonists [162] and group II or III 
mGluR agonists were found to attenuate the development of 
mechanical or cold allodynia [163-165] and c-fos expression 
in the superficial dorsal horn neurons [162] associated with 
CCI- and formalin [163-165]- or capsaicin- and glutamate 
[162]-induced neuropathic pain. A novel finding was that 
TRPM8-expressing DRG neurons could mediate icilin-, 
menthol- and moderate cooling-induced thermal and me-
chanical analgesia by acting on group II/III mGluRs, leading 
to inhibition of pain and behavioral algesia after chronic in-
jury of the rat sciatic nerve [166]. Namely, in contrast to 
TRPV1 and TRPA1, TRPM8 has an analgesic effect through 
Group II/III mGluRs, but not opioid receptors. On the other 
hand, TRPM8 knockout mice showed a complete inhibition 
of neuropathy (CCI model)-, or inflammation-induced (CFA 
application) cold allodynia, supporting the role of TRPM8 in 
injury-induced allodynia [167].  
 Psychophysical studies of both TRPM8 and TRPA1 acti-
vation in human volunteers by the application of either 40% 
menthol or 10% CA showed that CA induced a burning pain, 
heat hyperalgesia (allodynia), cold hypoalgesia and axon 
reflex (neurogenic inflammation), whereas menthol evoked a 
pinprick and a cold sensation, and cold hyperalgesia (allo-
dynia), but not axon reflex [168]. The authors concluded that 
TRPM8 and TRPA1 channels have remarkably different 
roles in the psychophysical pattern of heat and cold sensa-
tion: TRPA1 takes part in burning pain, heat allodynia and 
axon reflex, while TRPM8 in pinprick and cold allodynia. 
 Nilius and Voets [169] proposed the mirror image theory 
to explain warm and cool sensing; cold receptors (TRPM8) 
switch on upon cooling and concurrently off upon warming 
and vice versa. This theory is not likely to make clear the 
paradoxical cold sensation induced by noxious heat. Exceed-
ing over-threshold stimuli of heat or cold would also stimu-
late cold or heat receptor, generating the paradoxical sensa-
tion.  
 Collectively, whereas the activation of glial or immune 
cells following tissue damage, inflammation, infection and 
envenomation releases many kinds of cytokines, resulting in 
potentiation of nociceptors in PNS or CNS with regard to 
pathological pain (Fig. 1), acute noxious pain (physiological) 
seems to be closely related to unknown nociceptors without 
TRPV1, and glias or immune cells. 
CONCLUSION 
 Pathological pain is derived from peripheral and central 
sensitizations in which the thermosensors TRPV1, TRPA1 
and TRPM8 have a pivotal role in response to noxious 
physical or chemical stimuli. The former includes the sensi-
tization of peripheral nociceptive afferent terminals, the ge-
netical switching (up-regulation of thermo TRP channels) of 
primary sensory neurons, and the activation of peripheral 
glia (Schwann or satellite cells). The latter includes the sen-
sitization of secondary neurons in the superficial spinal dor-
sal horn, sprouting from Aβ primary afferents’ central termi-
nals and the activation of descending brain stem inhibitory 
neurons. Activation of glial and immune cells in both PNS 
and CNS are concurrent with the activation of nociceptive 
neurons via the release of cytokines and neuropeptides un-
derlying their mutual influences on the generation and main-
tenance of pathological pain. The signals responsible for 
neuropathic or inflammatory pain transmit to neighboring 
glia or those in the spinal cord dorsal horn after peripheral 
nerve injury must be a key cause of chronic pain. The growth 
factors (PDGF, TGF-β, CNTF, and FGF) produced in re-
sponse to nerve injury by sensory neurons, Schwann cells, 
and inflammatory cells are believed to be important and are 
centripetally transported [17]. To answer the above ques-
tions, two processes were proposed [40]. The first is deple-
tion of target-derived neurotrophic factors (a negative sig-
nal), and the second is production of injury-induced cyto-
kines and chemokines (a positive signal). These two signals 
are implicated in the alteration of gene expression in sensory 
neurons which results in abnormal electrical activity for 
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Fig .(1). Putative sequential phenomena relevance to pathological pain caused by tissue or peripheral nerve injury (referred to the References 
28 and 172). Many kinds of receptors expressed on nociceptors, interneurons in SG, peripheral and central glial or immune cells (including 
mast cells) and the intracellular second messengers for generation of abnormal pain were not illustrated (see the Text). NMDAR: NMDA 
receptor, PLE: Proteolytic enzymes, RVM: Rostral ventromedial medulla. 
pathological pain behavior [40]. The facilitation of glial anti-
inflammatory conditions (inactivation of glia) seems to be a 
more powerful approach to the therapeutic control of neuro-
pathic pain [170] as to the accompanying pain on the contra-
lateral side (mirror image neuropathy) as well [171]. In 
short, the activation of glial and immune cells is closely cor-
related with the sensitization of peripheral and central ther-
moTRP channels in chronic pain. The essential nature of 
pathological pain will be explained by interactions of ther-
moTRP channels and glial and immune cells. Studies on the 
chemical and molecular intracellular signal cascades in 
thermo TRP channels responsible for sensitization or desen-
sitization to pathological pain are now underway.  
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